Features

Who Owns this Joint?

As a result of the vacuum created by the withdrawal of COX-2 inhibitor drugs, fierce competition rages on between the medical and supplement industries, which are both vying for consumers that suffer from various joint ailments.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters